US Stock MarketDetailed Quotes

PYXS Pyxis Oncology

Watchlist

4.450
-0.050-1.11%

Close Apr 24 16:00 ET

4.610
+0.160+3.60%

Post 19:38 ET

258.69MMarket Cap-2405P/E (TTM)

Pyxis Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-33.43%82.2M

-53.21%17.77M

-10.70%25.35M

-29.56%18.12M

-33.24%20.95M

77.12%123.48M

131.18%37.97M

144.32%28.39M

333.02%25.73M

-12.15%31.39M

Selling and administrative expenses

-12.70%32.61M

-24.13%6.16M

13.98%10.67M

-21.34%6.73M

-20.01%9.05M

100.14%37.35M

-11.75%8.12M

148.12%9.36M

212.72%8.56M

283.01%11.32M

-General and administrative expense

-12.70%32.61M

-24.13%6.16M

13.98%10.67M

-21.34%6.73M

-20.01%9.05M

100.14%37.35M

-11.75%8.12M

148.12%9.36M

212.72%8.56M

283.01%11.32M

Research and development costs

-42.43%49.59M

-61.12%11.61M

-22.84%14.69M

-33.66%11.39M

-40.71%11.9M

68.70%86.13M

313.15%29.85M

142.50%19.03M

435.73%17.17M

-38.76%20.07M

Operating profit

33.43%-82.2M

53.21%-17.77M

10.70%-25.35M

29.56%-18.12M

33.24%-20.95M

-77.12%-123.48M

-131.18%-37.97M

-144.32%-28.39M

-333.02%-25.73M

12.15%-31.39M

Net non-operating interest income expense

139.87%6.63M

-14.85%1.59M

137.41%1.71M

909.76%1.66M

18,488.89%1.67M

11,917.39%2.76M

26,642.86%1.87M

11,883.33%719K

2,633.33%164K

125.00%9K

Non-operating interest income

139.87%6.63M

-14.85%1.59M

137.41%1.71M

909.76%1.66M

18,488.89%1.67M

11,917.39%2.76M

26,642.86%1.87M

11,883.33%719K

2,633.33%164K

125.00%9K

Other net income (expense)

1.78M

576K

598K

564K

38K

Other non- operating income (expenses)

--1.78M

--576K

--598K

--564K

--38K

----

Income before tax

38.87%-73.79M

56.80%-15.6M

16.71%-23.05M

37.79%-15.9M

38.68%-19.24M

-58.89%-120.72M

-114.52%-36.1M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

Income tax

Net income

38.87%-73.79M

56.80%-15.6M

16.71%-23.05M

37.79%-15.9M

38.68%-19.24M

-58.89%-120.72M

-114.52%-36.1M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

Net income continuous Operations

38.87%-73.79M

56.80%-15.6M

16.71%-23.05M

37.79%-15.9M

38.68%-19.24M

-58.89%-120.72M

-114.52%-36.1M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

Minority interest income

Net income attributable to the parent company

38.87%-73.79M

56.80%-15.6M

16.71%-23.05M

37.79%-15.9M

38.68%-19.24M

-58.89%-120.72M

-114.52%-36.1M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

38.87%-73.79M

56.80%-15.6M

16.71%-23.05M

37.79%-15.9M

38.68%-19.24M

-58.89%-120.72M

-114.52%-36.1M

-95.23%-27.67M

-213.80%-25.56M

14.79%-31.38M

Basic earnings per share

49.32%-1.85

68.27%-0.33

34.12%-0.56

48.10%-0.41

44.33%-0.54

59.22%-3.65

-99.13%-1.04

-90.29%-0.85

-207.76%-0.79

41.72%-0.97

Diluted earnings per share

49.32%-1.85

68.27%-0.33

34.12%-0.56

48.10%-0.41

44.33%-0.54

59.22%-3.65

-99.13%-1.04

-90.29%-0.85

-207.76%-0.79

41.72%-0.97

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-33.43%82.2M	-53.21%17.77M	-10.70%25.35M	-29.56%18.12M	-33.24%20.95M	77.12%123.48M	131.18%37.97M	144.32%28.39M	333.02%25.73M	-12.15%31.39M
Selling and administrative expenses	-12.70%32.61M	-24.13%6.16M	13.98%10.67M	-21.34%6.73M	-20.01%9.05M	100.14%37.35M	-11.75%8.12M	148.12%9.36M	212.72%8.56M	283.01%11.32M
-General and administrative expense	-12.70%32.61M	-24.13%6.16M	13.98%10.67M	-21.34%6.73M	-20.01%9.05M	100.14%37.35M	-11.75%8.12M	148.12%9.36M	212.72%8.56M	283.01%11.32M
Research and development costs	-42.43%49.59M	-61.12%11.61M	-22.84%14.69M	-33.66%11.39M	-40.71%11.9M	68.70%86.13M	313.15%29.85M	142.50%19.03M	435.73%17.17M	-38.76%20.07M
Operating profit	33.43%-82.2M	53.21%-17.77M	10.70%-25.35M	29.56%-18.12M	33.24%-20.95M	-77.12%-123.48M	-131.18%-37.97M	-144.32%-28.39M	-333.02%-25.73M	12.15%-31.39M
Net non-operating interest income expense	139.87%6.63M	-14.85%1.59M	137.41%1.71M	909.76%1.66M	18,488.89%1.67M	11,917.39%2.76M	26,642.86%1.87M	11,883.33%719K	2,633.33%164K	125.00%9K
Non-operating interest income	139.87%6.63M	-14.85%1.59M	137.41%1.71M	909.76%1.66M	18,488.89%1.67M	11,917.39%2.76M	26,642.86%1.87M	11,883.33%719K	2,633.33%164K	125.00%9K
Other net income (expense)	1.78M	576K	598K	564K	38K
Other non- operating income (expenses)	--1.78M	--576K	--598K	--564K	--38K	----	----	----	----	----
Income before tax	38.87%-73.79M	56.80%-15.6M	16.71%-23.05M	37.79%-15.9M	38.68%-19.24M	-58.89%-120.72M	-114.52%-36.1M	-95.23%-27.67M	-213.80%-25.56M	14.79%-31.38M
Income tax
Net income	38.87%-73.79M	56.80%-15.6M	16.71%-23.05M	37.79%-15.9M	38.68%-19.24M	-58.89%-120.72M	-114.52%-36.1M	-95.23%-27.67M	-213.80%-25.56M	14.79%-31.38M
Net income continuous Operations	38.87%-73.79M	56.80%-15.6M	16.71%-23.05M	37.79%-15.9M	38.68%-19.24M	-58.89%-120.72M	-114.52%-36.1M	-95.23%-27.67M	-213.80%-25.56M	14.79%-31.38M
Minority interest income
Net income attributable to the parent company	38.87%-73.79M	56.80%-15.6M	16.71%-23.05M	37.79%-15.9M	38.68%-19.24M	-58.89%-120.72M	-114.52%-36.1M	-95.23%-27.67M	-213.80%-25.56M	14.79%-31.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	38.87%-73.79M	56.80%-15.6M	16.71%-23.05M	37.79%-15.9M	38.68%-19.24M	-58.89%-120.72M	-114.52%-36.1M	-95.23%-27.67M	-213.80%-25.56M	14.79%-31.38M
Basic earnings per share	49.32%-1.85	68.27%-0.33	34.12%-0.56	48.10%-0.41	44.33%-0.54	59.22%-3.65	-99.13%-1.04	-90.29%-0.85	-207.76%-0.79	41.72%-0.97
Diluted earnings per share	49.32%-1.85	68.27%-0.33	34.12%-0.56	48.10%-0.41	44.33%-0.54	59.22%-3.65	-99.13%-1.04	-90.29%-0.85	-207.76%-0.79	41.72%-0.97
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall